Hecht H J, Szardenings M, Collins J, Schomburg D
GBF (Gesellschaft für Biotechnologische Forschung) Department of Molecular Structure Research, Braunschweig, Germany.
J Mol Biol. 1992 Jun 20;225(4):1095-103. doi: 10.1016/0022-2836(92)90107-u.
A modified version of the human pancreatic trypsin inhibitor (PSTI), generated in a protein-design project, has been crystallized in spacegroup P4(3) with lattice constants a = 40.15 A, c = 33.91 A. The structure has been solved by molecular replacement. Refinement of the structure by simulated annealing and conventional restrained least-squares yielded for 8.0 to 2.3 A data a final R-value of 19.1%. Differences to the known structures of porcine PSTI complexed with trypsinogen and modified human PSTI complexed with chymotrypsinogen occur at the flexible N-terminal part of the molecule. These differences are influenced by crystal packing, as are low temperature factors for the binding loop. The geometry of the binding loop is similar to the complexed structures.
在一个蛋白质设计项目中产生的人胰腺胰蛋白酶抑制剂(PSTI)的修饰版本,已在空间群P4(3)中结晶,晶格常数a = 40.15 Å,c = 33.91 Å。该结构已通过分子置换法解析。通过模拟退火和传统的约束最小二乘法对结构进行精修,对于8.0至2.3 Å的数据,最终R值为19.1%。与猪PSTI与胰蛋白酶原复合以及修饰的人PSTI与胰凝乳蛋白酶原复合的已知结构相比,差异出现在分子的柔性N端部分。这些差异受晶体堆积的影响,结合环的低温因子也是如此。结合环的几何形状与复合结构相似。